Quarterly report pursuant to Section 13 or 15(d)

Common Stock, and Preferred Stock (Details)

v3.23.2
Common Stock, and Preferred Stock (Details) - USD ($)
Apr. 19, 2023
Jun. 30, 2023
Jun. 13, 2023
Dec. 31, 2022
Common Stock, and Preferred Stock (Details) [Line Items]        
Common stock, shares authorized (in Shares)   500,000,000   500,000,000
Common stock par value   $ 0.1000   $ 0.1000
Aggregate purchase consideration (in Dollars)     $ 5,000,000  
Common stock shares (in Shares) 3,125,000   9,375,342  
Price per share $ 1.6   $ 1.6  
Exercise price per share $ 1.75      
Breakeven warrants expire duration 7 years      
pre-funded warrants [Member]        
Common Stock, and Preferred Stock (Details) [Line Items]        
Common stock shares (in Shares) 4,375,273      
Price per share $ 0.0001      
Exercise price per share $ 0.0001      
Breakeven warrants [Member]        
Common Stock, and Preferred Stock (Details) [Line Items]        
Common stock shares (in Shares) 1,875,069      
Common Stock [Member]        
Common Stock, and Preferred Stock (Details) [Line Items]        
Common stock, shares authorized (in Shares)   500,000,000    
Common stock par value   $ 0.0001    
Preferred Stock [Member]        
Common Stock, and Preferred Stock (Details) [Line Items]        
Preferred stock, shares authorized (in Shares)   10,000,000    
Preferred stock, par value   $ 0.0001    
HCA Healthcare, Inc. [Member]        
Common Stock, and Preferred Stock (Details) [Line Items]        
Aggregate purchase consideration (in Dollars) $ 11,999,999.29